Sidley Austin represented Resolian in the transaction. Resolian, a global bioanalytical contract research organization (CRO), announced the acquisition of Denali Medpharma (Denali), a leading China-based bioanalytical CRO....
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here